Esperion Therapeutics Inc. (ESPR) Dividend History
Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.
Last update 10/08/2019
Dividend Yield Summary
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 19.18 | 62.44 | 13.96 | 40.50 | 54.34 | 43.29 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |